Mind Medicine (MindMed) Inc. Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mind Medicine (MindMed) Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • Mind Medicine (MindMed) Inc. Return On Equity for the quarter ending September 30, 2024 was -53 %, a 16.6% increase year-over-year.
  • Mind Medicine (MindMed) Inc. annual Return On Equity for 2023 was -93.3 %, a 132% decline from 2022.
  • Mind Medicine (MindMed) Inc. annual Return On Equity for 2022 was -40.2 %, a 27.9% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -53 +10.6 +16.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -71.3 -15.6 -28% Apr 1, 2024 Jun 30, 2024
Q1 2024 -105 -60.1 -133% Jan 1, 2024 Mar 31, 2024
Q4 2023 -93.3 -53.2 -132% Oct 1, 2023 Dec 31, 2023
Q3 2023 -63.6 -15 -31% Jul 1, 2023 Sep 30, 2023
Q2 2023 -55.7 -7.6 -15.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -45.2 +17.4 +27.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -40.2 +15.6 +27.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -48.5 Jul 1, 2022 Sep 30, 2022
Q2 2022 -48.1 Apr 1, 2022 Jun 30, 2022
Q1 2022 -62.6 Jan 1, 2022 Mar 31, 2022
Q4 2021 -55.7 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.